Work spans neurodegeneration, CNS disease biomarkers, and targeted RNA nanomedicine. Focus on pathway-driven target discovery, serum biomarker validation for tumor activity, and leukocyte-selective siRNA delivery for immunomodulation, plus studies linking environmental exposures to ocular health.